Sen. Collins, Colleagues Introduce Bipartisan Bill to Lower Costs for Key Prescription Drugs
June 07, 2022
June 07, 2022
WASHINGTON, June 7 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
U.S. Senator Susan Collins (R-ME), a member of the Senate Health Committee, joined Senators Tim Kaine (D-VA) and Maggie Hassan (D-NH) in introducing legislation to strengthen the FDA approval process pipeline and increase transparency for critical medicines, which would lower costs and increase availability of key medications.
"Millions of Americans are struggling with the high . . .
U.S. Senator Susan Collins (R-ME), a member of the Senate Health Committee, joined Senators Tim Kaine (D-VA) and Maggie Hassan (D-NH) in introducing legislation to strengthen the FDA approval process pipeline and increase transparency for critical medicines, which would lower costs and increase availability of key medications.
"Millions of Americans are struggling with the high . . .